Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma

NVS' Q3 Earnings Top Estimates on Strong Key Drug Sales, Revenues Miss

Buy, Hold or Sell ABBV Stock? Key Tips Ahead of Q3 Earnings

Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories

Roche Holding AG (RHHBF) Stock Price, News, Quote & History

Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer

Genentech’s Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS G12C-mutated Lung Cancer

Moderna’s Cancer-Vaccine Leak Spurs Panic Selling. Wall Street Wanted a Cure.

Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)

Roche Holding Ltd (RHHBF) Q3 FY2026 earnings call transcript

Roche says German investments are on hold

Roche and Hansoh ink cancer drug deal potentially worth more than $14B

Roche's experimental eye drug shows vision improvements in trials (RHHBY:OTCMKTS)

Roche: Risk-Reward Has Become More Balanced (Rating Downgrade)

Roche jumps despite reiterated 2026 outlook (RHHBY:OTCMKTS)